Guidelines for Kidney Transplantation in Patients with HIV Disease
Jul 2015
Addendum to Living Kidney Donor Guidelines
Dec 2014
2015
Detection and characterisation of clinically relevant antibodies in allotransplantation (joint with BSHI)
Jun 2014
Living donor kidney transplantation (joint with RA)
May 2011
2015
Transplantation 2012; 93: 666–73
BTS clinical practice guidelines
Nov 2011
UK Liver Transplant Group Recommendations for Alcohol-Related Liver Disease
2011
Assessment of the potential kidney transplant recipient (RA; endorsed by BTS)
Jan 2011
2014
Nephron Clin Pract 2011; 118 (suppl 1): c209-24
BTS/ICS Consensus guidelines on Organ Donation after Circulatory Death
Dec 2010
Post-operative care of the kidney transplant recipient (RA; endorsed by BTS)
August 2010
Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients (joint with BSCH)
Jun 2010
2015
Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients (joint with BSCH)
Jun 2010
2015
Guidelines for Living Donor Kidney Transplantion in High-Risk Adult Patients
May 2008
Guidelines for Liver Transplantation in Patients with HIV Infection
2005
United Kingdom Guidelines for Living Donor Kidney Transplantation
2005
Guidelines
These guidelines are only guides to best practice which inevitably changes with passage of time. All practitioners need to undertake clinical care on an individualised basis and keep themselves up to date with changes in practice of clinical medicine.
The British Transplantation Society guidelines (“the Guidelines”) have been compiled by working parties of the British Transplantation Society.
The Guidelines represent the collective opinions of a number of experts in the field and do not have the force of law.
The Guidelines contain information/guidance for use by practitioners as a best practice tool. It follows that the Guidelines should be interpreted to the spirit rather than the letter of their contents. The opinions presented in the Guidelines are subject to change and should not be considered to be a treatment recommendation for any individual patient.
The British Transplantation Society cannot attest to the accuracy, completeness or currency of the opinions contained herein and does not accept any responsibility or liability for any loss or damage caused to any practitioner or any third party as a result of any reliance being placed on the Guidelines or as a result of any inaccurate or misleading opinion contained in the Guidelines”.
Active NICE Standards and Guidelines
- TA165 Organ preservation (renal) – machine perfusion and static storage
- TA481 Immunosuppressive therapy for kidney transplant in adults
- TA482 Immunosuppressive therapy for kidney transplant in children and young people
- CG135 Organ donation
- IPG170 Living donor lung transplantation for end-stage lung disease
- IPG177 Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery
- IPG257 Allogeneic pancreatic islet transplantation for type 1 diabetes mellitus
- IPG535 Living-donor liver transplantation
BTS Latest News
The latest news and events from the British Transplantation Society
